| Product NDC: | 55045-3198 |
| Proprietary Name: | Tamiflu |
| Non Proprietary Name: | oseltamivir phosphate |
| Active Ingredient(s): | 12 mg/mL & nbsp; oseltamivir phosphate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55045-3198 |
| Labeler Name: | Dispensing Solutions, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021246 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20001214 |
| Package NDC: | 55045-3198-2 |
| Package Description: | 1 BOTTLE, GLASS in 1 BOX (55045-3198-2) > 25 mL in 1 BOTTLE, GLASS |
| NDC Code | 55045-3198-2 |
| Proprietary Name | Tamiflu |
| Package Description | 1 BOTTLE, GLASS in 1 BOX (55045-3198-2) > 25 mL in 1 BOTTLE, GLASS |
| Product NDC | 55045-3198 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | oseltamivir phosphate |
| Dosage Form Name | POWDER, FOR SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20001214 |
| Marketing Category Name | NDA |
| Labeler Name | Dispensing Solutions, Inc. |
| Substance Name | OSELTAMIVIR PHOSPHATE |
| Strength Number | 12 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Neuraminidase Inhibitor [EPC],Neuraminidase Inhibitors [MoA] |